İnsan kronik miyeloid lösemi K562 hücrelerinde karbakolün apoptoza etkisi
Amaç: Muskarinik reseptörler merkezi sinir sisteminde
Effects of carbachol on apoptosis in human chronic myelogenous leukemic K562 cell line
Objectives: Muscarinic receptors mediate diverse actions of
___
- 1. Pierce KL, Premont RT, Lefkowitz RJ. Seven transmembrane
receptors. Nat Rev Mol Cell Biol 2002;3:639-50. doi:
10.1038/nrm908
- 2. Haga T. Molecular properties of muscarinic acetylcholine
receptors. Proc Jpn Acad Ser B Phys Biol Sci 2013;89:226-
56. doi: 10.2183/pjab.89.226
- 3. Gutkind JS, Novotny EA, Brann MR, Robbins KC. Muscarinic
acetylcholine receptor subtypes as agonist-dependent
oncogenes. Proc Natl Acad Sci USA 1991;88:4703– 07.
- 4. Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK,
Shah GV. Muscarinic cholinergic receptors promote growth
of human prostate cancer cells. Prostate 1997; 30:160-6.
doi: 10.1002/(SICI)1097-0045(19970215)30:3<160::AID –
PROS3>3.0.CO;2-Q
- 5. Luthin GR, Wang P, Zhou H, Dhanasekaran D, Ruggieri MR.
Role of m1 receptor-G protein coupling in cell proliferation
in the prostate. Life Sci 1997;60:963-8. doi: 10.1016/S0024-
3205(97)00035-0
- 6. Wang L, Jiang R, Song SD, Hua ZS, Wang JW, Wang
YP. Angelica sinensis polysaccharide induces erythroid
differentiation of human chronic myelogenous leukemia
k562 cells. Asian Pac J Cancer Prev 2015;16:3715-21.
- 7. Taverna S, Giallombardo M, Pucci M, et al. Curcumin
inhibits in vitro and in vivo chronic myelogenous leukemia
cells growth: a possible role for exosomal disposal of
miR-21. Oncotarget 2015;6:21918-33. doi: 10.18632/
oncotarget.4204
- 8. Klein E, Ben-Bassat H, Neumann H, et al. Properties of
the K562 cell line, derived from a patient with chronic
myeloid leukemia. Int J Can 1976;18:421-31. doi: 10.1002/
ijc.291.018.0405
- 9. Cabadak H, Aydin B, Kan B. Regulation of M2, M3, and M4
muscarinic receptor expression in K562 chronic myelogenous
leukemic cells by carbachol. J Recept Signal Transd Res
2011;31:26-32. doi: 10.3109/10799.893.2010.506484
- 10. Fleisher TA. Apoptosis. Ann Allergy Asthma Immunol
1997;78:245-9. doi: 10.1016/S1081-1206(10)63176-6
- 11. Ashkenazi A, Dixit VM. Death receptors: Signaling and
modulation. Science 1998; 281:1305-8. doi: 10.1126/
science.281.5381.1305
- 12. Green DR, Reed JC. Mitochondria and apoptosis. Science
1998;281:1309-12. doi: 10.1126/science.281.5381.1309
- 13. Hughes D, Mehmet H. Cell proliferation and apoptosis.
Advanced Methods. Oxford: Bios Scientific Publishers
Limited, 2003.
- 14. Wyllie AH, Moms RG, Smith AL, Dunlop D. Chromatin
cleavage in apoptosis: Association with condensed chromatin
morphology and dependence on macromolecular synthesis.
J Pathol 1984;142: 67. doi: 10.1002/path.171.142.0112.
- 15. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance
of apoptosis. Int Rev Cytol 1980;68:251-306.
- 16. Rosenblum K, Futter M, Jones M, E. Hulme C, Bliss T V
P, “ERKI/II regulation by the muscarinic acetylcholine
receptors in neurons,” J Neurosci 2000;20:977-85. doi:
10.1523/JNEUROSCI.20-03-00977.2000
- 17. Yu H, Xia H, Tang Q, et al. Acetylcholine acts through
M3 muscarinic receptor to activate the EGFR signaling
and promotes gastric cancer cell proliferation. Sci Rep
2017;7:40802. doi: 10.1038/srep40802
- 18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein
measurement with the Folin phenol reagent. J Biol
Chem 1951;193:265-75.
- 19. Aydın B, Kan B, Cabadak H. The role of intracellular
pathways in the proliferation of human K562 cells that is
mediated by muscarinic receptors. Leukemia Res 2013;37:
1144-9. doi: 10.1016/j.leukres.2013.05.018
- 20. Schuller HM. Cell type specific, receptor-mediated
modulation of growth kinetics in human lung cancer
cell lines by nicotine and tobacco-related nitrosamines.
Biochem Pharmacol 1989;38:3439-42. doi: 10.1016/0006-
2952(89)90112-3
- 21. Maneckjee R, Minna JD. Opioid and nicotine receptors affect
growth regulation of human lung cancer cell lines. Proc Natl
Acad Sci USA 1990;87:3294-8. doi: 10.1073/pnas.87.9.3294.
- 22. Cheng K, Zimniak P, Raufman JP. Transactivation of the
epidermal growth factor receptor mediates cholinergic
agonist-induced proliferation of H508 human colon cancer
cells. Cancer Res 2003;63:6744–50.
- 23. Shant J, Cheng K, Marasa BS, Wang JY, Raufman JP. Aktdependent
NF-kappaB activation is required for bile acids to
rescue colon cancer cells from stress-induced apoptosis. Exp
Cell Res 2009;315:432-50. doi: 10.1016/j.yexcr.2008.11.003
- 24. Peng Z, Heath J, Drachenberg C, Raufman JP, Xie G.
Cholinergic muscarinic receptor activation augments murine
intestinal epithelial cell proliferation and tumorigenesis. BMC
Cancer 2013;13:204. doi: 10.1186/1471-2407-13-204
- 25. Raufman JP, Shant J, Xie G, et al. Muscarinic receptor
subtype-3 gene ablation and scopolamine butylbromide
treatment attenuate small intestinal neoplasia in Apcmin/+
mice. Carcinogenesis 2011;32:1396-402. doi: 10.1093/
carcin/bgr118
- 26. Raufman JP, Samimi R, Shah N,et al. Genetic ablation of M3
muscarinic receptors attenuates murine colon epithelial cell
proliferation and neoplasia. Cancer Res 2008;68:3573-8. doi:
10.1158/0008-5472.CAN-07-6810
- 27. Cheng K, Shang AC, Drachenberg CB, Zhan M, Raufman
J P. Differential expression of M3 muscarinic receptors in
progressive colon neoplasia and metastasis. Oncotarget
2017;8: 21106-14. doi: 10.18632/oncotarget.15500
- 28. Cabadak H, Kücükibrahimoğlu E, Aydin B, Kan B, Gören
MZ. Muscarinic receptor- mediated nitric oxide release in a
K562 erythroleukaemia cell line. Auton Autacoid Pharmacol
2009;29:109-15. doi: 10.1111/j.1474-8673.2009.00431.x
- 29. Cabadak H, Aydin B, Kan B. Muscarinic receptor mediated
cAMP response in human K562 chronic myelogenous
leukemia cells. Turk J Biochem 2011;36:18-92.
- 30. Kodaira M, Kajimura M, Takeuchi K, Lin S, Hanai H,
Kaneko E. Functional muscarinic m3 receptor expressed in
gastric cancer cells stimulates tyrosine phosphorylation and
MAP kinase. J Gastroenterol 1999;34: 163-71. doi: 10.1007/
s005.350.050238
- 31. Fujii T, Tsuchiya T, Yamada S, et al. Localization and
synthesis of acetylcholine in human leukemic T cell lines. J
Neurosci Res 1996;44:66-72. doi: 10.1002/(SICI)1097-
4547(19960401)44:1<66::AID-JNR9>3.0.CO;2-G
- 32. Kawashima K, Fujii T. Extraneuronal cholinergic system in
lymphocytes. Pharmacol Ther 2000;86:29-48. doi: 10.1016/
S0163-7258(99)00071-6.
- 33. Shah N, Khurana S, Cheng K, Raufman JP. Muscarinic
receptors and ligands in cancer. Am J Physiol Cell Physiol
2009;296:C221-32. doi: 10.1152/ajpcell.00514.2008
- 34. Guizetti M, Moore NH, Van DeMark KL, Giordano G, Costa
LG. Muscarinic receptor-activated signal transduction
pathways involved in the neuritogenic effect of astrocytes in
hippocampal neurons. Eur J Pharmacol 2011;659:102-7. doi:
10.1016/j.ejphar.2011.03.019